Instituto Butantan, São Paulo, Brazil.
Instituto de Química, Universidade de São Paulo, São Paulo, Brazil.
Alzheimers Dement. 2021 Nov;17(11):1818-1831. doi: 10.1002/alz.12352. Epub 2021 Apr 21.
Dementia has been associated with COVID-19 prevalence, but whether this reflects higher infection, older age of patients, or disease severity remains unclear.
We investigated a cohort of 12,863 UK Biobank community-dwelling individuals > 65 years old (1814 individuals ≥ 80 years old) tested for COVID-19. Individuals were stratified by age to account for age as a confounder. Risk factors were analyzed for COVID-19-positive diagnosis, hospitalization, and death.
All-cause dementia, Alzheimer's disease (AD), and Parkinson's disease (PD) were associated with COVID-19-positive diagnosis, and all-cause dementia and AD remained associated in individuals ≥ 80 years old. All-cause dementia, AD, or PD were not risk factors for overall hospitalization, but increased the risk of hospitalization of COVID-19 patients. All-cause dementia and AD increased the risk of COVID-19-related death, and all-cause dementia was uniquely associated with increased death in ≥ 80-year-old patients.
All-cause dementia and AD are age-independent risk factors for disease severity and death in COVID-19.
痴呆与 COVID-19 的流行有关,但这是否反映了更高的感染率、患者年龄更大还是疾病严重程度仍不清楚。
我们调查了英国生物银行(UK Biobank) 12863 名居住在社区的 65 岁以上(≥80 岁的 1814 人)个体的队列,这些个体接受了 COVID-19 检测。个体按年龄分层,以考虑年龄作为混杂因素。分析了 COVID-19 阳性诊断、住院和死亡的危险因素。
全因痴呆、阿尔茨海默病(AD)和帕金森病(PD)与 COVID-19 阳性诊断相关,≥80 岁的个体中全因痴呆和 AD 仍然相关。全因痴呆、AD 或 PD 不是总住院的危险因素,但增加了 COVID-19 患者住院的风险。全因痴呆和 AD 增加了 COVID-19 相关死亡的风险,全因痴呆与≥80 岁患者的死亡增加独特相关。
全因痴呆和 AD 是 COVID-19 严重程度和死亡的与年龄无关的危险因素。